News
-
EMA Pharmacovigilance Risk Assessment Committee (PRAC) recommends modified-release paracetamol to be removed from the market
04.09.2017Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August-1 September 2017.
-
On July 18, 2017 at 10.00-12.00 am the round table discussion “The Future of Distribution Contracts in the Pharmaceutical Market in the Light of the Adoption of Standard Requirements on Vertical Concerted Actions” will be held
12.07.2017The event will be held by Legal Alliance Company together with AIPM Ukraine at the press center of LIGABusinessInform (Kiev, 23 Shamrylo Str.) .
-
AIPM Ukraine, being a partner of specialized conference “Pharmbudget-2018”, invites you to participate in this event
10.07.2017Pharmbudget Cconference-workshop always has a strategic programme, based on the study of your professional thoughts and created specifically for the leaders of the pharmaceutical companies.
The main benefit of attending the conference is the opportunity to take part in discussing the ideas of the pharmaceutical sector’s development.
Pharmbudget is a professional communication platform, where you can find out about relevant short-term development trends in the economic situation of pharmaceutical market.
Date: 21 September 2017
Venue: Premier Hotel Rus, 4, Hospitalna street, Kyiv
Fee: 5950,00 UAH
CONTACT DETAILS: tel./fax: +38(044) 585-97-10 (ext. – 313), e-mail: yuliya.gulenko@morion.ua
-
AIPM Ukraine took part in Forum on the Serving People, Improving Health Project for Ukraine
12.06.2017The development objectives of the Serving People, Improving Health Project for Ukraine are to improve the quality of health services in selected Oblasts, with special focus on primary and secondary prevention of cardiovascular diseases and cancer, and to enhance efficiency of the health care system.
-
WHO updates Essential Medicines List with new advice on use of antibiotics, and adds medicines for hepatitis C, HIV, tuberculosis and cancer
07.06.2017New advice on which antibiotics to use for common infections and which to preserve for the most serious circumstances is among the additions to the WHO Model list of essential medicines for 2017. Other additions include medicines for HIV, hepatitis C, tuberculosis and leukaemia.